Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Hemoglobin ; 45(2): 112-118, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33829933

ABSTRACT

The ß-thalassemias and sickle cell disorders pose a considerable health burden in India. Of the more than 10,000 annual births of children with a severe hemoglobinopathy, only around 10.0% are managed optimally. Thus, genetic counseling and prenatal diagnosis (PND) is a valid option for a large and diverse country. Our center was one of the first to initiate PND and we present our experience over 30 years to evaluate the impact of awareness in changing the trends of PND of hemoglobinopathies. Both second and first-trimester diagnoses were undertaken by fetoscopy/cordocentesis and globin biosynthesis/high-performance liquid chromatography (HPLC) analysis of fetal blood and chorionic villus sampling (CVS) and DNA analysis. Over 30 years, 3478 couples (first trimester: 2475; second trimester: 1003) from all over India were offered PND. The number of couples coming in the first trimester increased significantly over each decade and couples coming prospectively increased from 2.5 to 18.4%. A cost-effective stepwise approach was used for molecular analysis. Eight hundred and one fetuses (23.0%) were affected and all except three couples opted for termination of these pregnancies. Genetic counseling and PND is the only way to reduce the burden of disease. With awareness, there was a shift from second trimester to first trimester PND over each decade, with an increasing number of couples coming during the first pregnancy. There are only 15 to 20 centers in India offering PND. We have compared our study with other reports on PND from different regions in India.


Subject(s)
Hemoglobinopathies , beta-Thalassemia , Cost of Illness , Female , Genetic Counseling , Hemoglobinopathies/diagnosis , Hemoglobinopathies/epidemiology , Hemoglobinopathies/genetics , Humans , Pregnancy , Prenatal Diagnosis
2.
Vaccine ; 38(50): 7989-7997, 2020 11 25.
Article in English | MEDLINE | ID: mdl-33158592

ABSTRACT

Pharmacological therapies for the treatment of cocaine addiction have had disappointing efficacy, and the lack of recent developments in the clinical care of cocaine-addicted patients indicates a need for novel treatment strategies. Recent studies have shown that vaccination against cocaine to elicit production of antibodies that reduce concentrations of free drug in the blood is a promising method to protect against the effects of cocaine and reduce rates of relapse. However, the poorly immunogenic nature of cocaine remains a major hurdle to active immunization. Therefore, we hypothesized that strategies to increase targeted exposure of cocaine to the immune system may produce a more effective vaccine. To specifically direct an immune response against cocaine, in the present study we have conjugated a cocaine analog to a dendrimer-based nanoparticle carrier with MHC II-binding moieties that previously has been shown to activate antigen-presenting cells necessary for antibody production. This strategy produced a rapid, prolonged, and high affinity anti-cocaine antibody response without the need for an adjuvant. Surprisingly, additional evaluation using multiple adjuvant formulations in two strains of inbred mice found adjuvants were either functionally redundant or deleterious in the vaccination against cocaine using this platform. The use of conditioned place preference in rats after administration of this vaccine provided proof of concept for the ability of this vaccine to diminish cocaine reward. Together these data demonstrate the intrinsic efficacy of an immune-targeting dendrimer-based cocaine vaccine, with a vast potential for design of future vaccines against other poorly immunogenic antigens by substitution of the conjugated cargo.


Subject(s)
Cocaine , Dendrimers , Nanoparticles , Vaccines , Adjuvants, Immunologic , Animals , Humans , Mice , Rats , Vaccination
3.
Int J Lab Hematol ; 41(2): 218-226, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30489691

ABSTRACT

INTRODUCTION: The hemoglobinopathies pose a significant health burden in India. Apart from the ß thalassemias and sickle cell disorders, α thalassemias and structural hemoglobin variants are also common. Here we have reviewed the phenotypic and molecular diversity of hemoglobinopathies encountered at a referral center in western India over a period of 15 years. MATERIALS AND METHODS: Screening for hemoglobinopathies was done using HPLC and cellulose acetate electrophoresis. Molecular characterization was done using Covalent Reverse Dot Blot Hybridization (CRDB), Amplification Refractory Mutation System (ARMS), GAP PCR and direct DNA sequencing. RESULTS: The study includes 31 075 individuals who were referred for diagnosis of hemoglobinopathies and prenatal diagnosis. Of these 14 423 individuals showed various hemoglobin abnormalities. Beta genotyping in 5615 individuals showed the presence of 49 ß thalassemia mutations. 143 ß thalassemia heterozygotes had normal or borderline HbA2 levels. We identified three δ gene mutations (HbA2 Pellendri, HbA2 St.George, HbA2 Saurashtra) in ß thalassemia heterozygotes leading to normal HbA2 levels. The commonest defects among the raised Hb F determinants were Gγ(Αγδß)0 Indian inversion and the HPFH-3 Indian deletion. A total of 312 individuals showed the presence of α thalassemia, of which 12.0% had a single α gene deletion (-α/αα). HbH disease was identified in 29 cases with 10 different genotypes. Alpha globin gene triplication was seen in 2.1% of ß thalassemia heterozygotes with a thalassemia intermedia phenotype. Seven unusual α chain variants and eight uncommon ß chain variants were identified. CONCLUSION: The repertoire of molecular defects seen in the different globin genes will be valuable for management and control of these disorders both in India as well as in other countries where there is a huge influx of migrant populations from India.


Subject(s)
Hemoglobins/genetics , Mutation , beta-Thalassemia/genetics , Female , Humans , India/epidemiology , Male , Retrospective Studies , beta-Thalassemia/epidemiology
4.
Hemoglobin ; 42(5-6): 297-301, 2018.
Article in English | MEDLINE | ID: mdl-30626279

ABSTRACT

Genetic structure of the Indian population is influenced by waves of several immigrants from West Eurasia. Therefore, genetic information of various ethnic groups is valuable to understand their origins, the pattern of migration as well as the genetic relationship between them. No genetic data is available on Pathare Prabhu, which is a small indigenous Hindu community from Mumbai, Maharashtra State, India. The aim of this study was to screen the Pathare Prabhus for hemoglobinopathies, which is a major public health problem in India. Two hundred and fifty-seven unrelated Pathare Prabhus subjects were screened for various hemoglobinopathies. Complete blood counts (CBC) were done on an automated hematology counter. High performance liquid chromatography (HPLC) was used to identify ß-thalassemia (ß-thal) carriers. Molecular characterization of the ß gene defects was done by reverse dot-blot hybridization, amplification refractory mutation system (ARMS) and DNA sequencing. Deletional α-thalassemia (α-thal) was detected by multiplex polymerase chain reaction (PCR). Hb A2-Saurashtra (HBD: c.301C>T) was identified by DNA sequencing; its modeling was also done. The prevalence of ß-thal was 3.89%, while deletional α-thal was 5.4%. The initiation codon (ATG>ACG) (HBB: c.2T>C) was seen in eight individuals (80.0%), Hb D-Punjab (HBB: c.364G>C) and Hb A2-Saurashtra, was found in two and one individual, respectively. A community-specific ß-thal mutation was found in Pathare Prabhus in significant proportions. This information is useful in developing an algorithm for a prenatal diagnosis (PND) program.


Subject(s)
Hemoglobinopathies/ethnology , Mutation , beta-Globins/genetics , delta-Globins/genetics , Genetic Testing/methods , Hemoglobinopathies/diagnosis , Humans , India , Molecular Epidemiology , Population Groups
5.
Cell Death Dis ; 8(5): e2826, 2017 05 25.
Article in English | MEDLINE | ID: mdl-28542141

ABSTRACT

The process of controlled cellular death known as apoptosis has an important central role not only in normal homeostatic maintenance of tissues, but also in numerous diseases such as cancer, neurodegenerative, autoimmune, and cardiovascular diseases. As a result, new technologies with the capability to selectively detect apoptotic cells represent a central focus of research for the study of these conditions. We have developed a new biosensor for the detection of apoptotic cells, incorporating the targeted selectivity for apoptotic cells from Annexin V with the sensitivity of bioluminescence signal generation from a serum-stable mutant of Renilla luciferase (RLuc8). Our data presents a complete characterization of the structural and biochemical properties of this new Annexin-Renilla fusion protein (ArFP) construct, as well as a validation of its ability to detect apoptosis in vitro. Moreover, this work represents the first report of a bioluminescent Annexin V apoptosis sensor utilized in vivo. With this new construct, we examine apoptosis within disease-relevant animal models of surgery-induced ischemia/reperfusion, corneal injury, and retinal cell death as a model of age-related macular degeneration. In each of these experiments, we demonstrate successful application of the ArFP construct for detection and bioluminescence imaging of apoptosis within each disease or treatment model. ArFP represents an important new tool in the continuously growing kit of technologies for apoptosis detection, and our results from both in vitro and in vivo experiments suggest a diverse range of potential clinically relevant applications including cancer therapeutic screening and efficacy analysis, atherosclerosis and cardiovascular disease detection, and the monitoring of any number of other conditions in which apoptosis has a central role.


Subject(s)
Annexin A5/metabolism , Apoptosis , Luminescence , Molecular Probes/metabolism , Animals , Calorimetry , Disease Models, Animal , Female , Humans , Jurkat Cells , Luciferases, Renilla/metabolism , Mice, Inbred BALB C , Models, Biological , Rats , Recombinant Fusion Proteins/metabolism
6.
Ann Hematol ; 94(12): 1953-8, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26319530

ABSTRACT

Co-inheritance of triplicated α-genes can alter the clinical and hematological phenotypes of ß-thalassemias. We evaluated the phenotypic diversity and transfusion requirements in ß-thalassemia heterozygotes, homozygotes, and normal individuals with associated α-gene triplication. Clinical and hematological evaluation was done and the ß-thalassemia mutations characterized by a covalent reverse dot blot hybridization/amplification refractory mutation system. Alpha-globin gene triplication was assessed by multiplex PCR. During the last 2.5 years, 181 ß-thalassemia patients and ß-thalassemia carriers with an unusual clinical presentation were referred to us for screening for the presence of associated α-globin gene triplication. Twenty-nine of them had associated α-gene triplication (3 ß-thalassemia homozygotes or compound heterozygotes and 26 ß-thalassemia heterozygotes). One ß-thalassemia compound heterozygote [IVS 1-5 (G → C) + CD 41/42 (-CTTT)] was anemic at birth and required blood transfusions unusually early by 6 weeks of age. The second patient (4.5 years) was also clinically severe and became transfusion dependent in spite of having one mild ß-thalassemia mutation [Capsite +1 (A → C)]. The third case (3.5 years) who was homozygous for a mild ß-gene mutation [-88 (C → T)] with α gene triplication was untransfused. The 26 ß-thalassemia heterozygotes with associated triplicated α-genes presented variably, with a ß-thalassemia intermedia-like presentation. While screening the family members of all these cases, we found another 10 ß-thalassemia heterozygotes and 9 normal individuals with α-globin gene triplication; however, all of them were asymptomatic. Beta-thalassemia carriers, homozygotes, and compound heterozygotes with an unusual presentation should be screened for the possible presence of associated α-globin gene triplication which could influence the clinical and hematological presentation.


Subject(s)
Blood Transfusion , Gene Amplification , Heterozygote , Homozygote , Phenotype , alpha-Globins/genetics , beta-Thalassemia/genetics , beta-Thalassemia/therapy , Child, Preschool , Female , Humans , Infant
7.
Hemoglobin ; 36(2): 114-23, 2012.
Article in English | MEDLINE | ID: mdl-22296681

ABSTRACT

We report the problems in diagnosis faced by two families referred for prenatal diagnosis of thalassemia where cordocentesis and fetal blood analysis by high performance liquid chromatography (HPLC) had to be done. The Hb A levels of the fetal blood measured by HPLC on the VARIANT™ Hemoglobin Testing System were 1.2 and 6.7%, respectively, suggestive of a heterozygous ß-thalassemia (ß-thal) fetus in the first case and a normal fetus in the second case. In one family, one of the parents had a borderline Hb A(2) level and in the other, one parent had normal RBC indices. However, DNA sequencing, done later, showed that in the first case the fetus was a compound heterozygote for the IVS-I-5 (G>C) and the polyadenylation signal site [poly A (T>C)] mutation, while in the second case, the fetus was homozygous for the poly A mutation. This emphasizes that characterization of ß-thal mutations must be done whenever one of the parents has a borderline Hb A(2) level or normal RBC indices, and one should not rely on fetal blood analysis by HPLC for prenatal diagnosis of ß-thal so as to avoid misdiagnosis.


Subject(s)
Diagnostic Errors , Hemoglobin A2/genetics , Poly A/genetics , beta-Thalassemia/diagnosis , Base Sequence , Biomarkers/blood , Chromatography, High Pressure Liquid , Cordocentesis , DNA Mutational Analysis , Female , Fetal Blood/chemistry , Hemoglobin A2/analysis , Heterozygote , Homozygote , Humans , Molecular Sequence Data , Mutation , Poly A/blood , Pregnancy , Pregnancy Trimester, Second , Prenatal Diagnosis , beta-Thalassemia/blood , beta-Thalassemia/genetics
8.
Extremophiles ; 15(6): 673-90, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21918795

ABSTRACT

Two 16S rRNA gene clone libraries (KF and KS) were constructed using two soil samples (K7s and K8s) collected near Kafni Glacier, Himalayas. The two libraries yielded a total of 648 clones. Phyla Actinobacteria, Bacteroidetes, Chloroflexi Firmicutes, Proteobacteria, Spirochaetae, Tenericutes and Verrucomicrobia were common to the two libraries. Phyla Acidobacteria, Chlamydiae and Nitrospirae were present only in KF library, whereas Lentisphaerae and TM7 were detected only in KS. In the two libraries, clones belonging to phyla Bacteroidetes and Proteobacteria were the most predominant. Principal component analysis (PCA) revealed that KF and KS were different and arsenic content influenced the differences in the percentage of OTUs. PCA indicated that high water content in the K8s sample results in high total bacterial count. PCA also indicated that bacterial diversity of KF and KS was similar to soils from the Pindari Glacier, Himalayas; Samoylov Island, Siberia; Schrimacher Oasis, Antarctica and Siberian tundra. The eleven bacterial strains isolated from the above two soil samples were phylogenetically related to six different genera. All the isolates were psychro-, halo- and alkalitolerant. Amylase, lipase and urease activities were detected in the majority of the strains. Long chain, saturated, unsaturated and branched fatty acids were predominant in the psychrotolerant bacteria.


Subject(s)
Bacteria/classification , Biodiversity , Soil Microbiology , Bacteria/genetics , Base Sequence , Colony Count, Microbial , DNA Primers , India , Phylogeny , Polymerase Chain Reaction , Principal Component Analysis , RNA, Ribosomal, 16S/genetics
9.
Extremophiles ; 15(1): 1-22, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21061031

ABSTRACT

Three 16S rRNA gene clone libraries (P1L, P4L and P8L) were constructed using three soil samples (P1S, P4S and P8S) collected near Pindari glacier, Himalayas. The three libraries yielded a total of 703 clones. Actinobacteria, Firmicutes and Proteobacteria were common to the three libraries. In addition to the above P1L and P8L shared the phyla Acidobacteria, Bacteroidetes, Gemmatimonadetes and Planctomycetes. Phyla Chlamydiae, Chlorobi, Chloroflexi, Dictyoglomi, Fibrobacteres, Nitrospirae, Verrucomicrobia, candidate division SPAM and candidate TM7s TM7a phylum were present only in P1L. Rarefaction analysis indicated that the bacterial diversity in P4S and P8S soil samples was representative of the sample. Principal component analysis (PCA) revealed that P1S and P8S were different from P4S soil sample. PCA also indicated that arsenic content, pH, Cr and altitude influence the observed differences in the percentage of specific OTUs in the three 16S rRNA gene clone libraries. The observed bacterial diversity was similar to that observed for other Himalayan and non-polar cold habitats. A total of 40 strains of bacteria were isolated from the above three soil samples and based on the morphology 20 bacterial strains were selected for further characterization. The 20 bacteria belonged to 12 different genera. All the isolates were psychro-, halo- and alkalitolerant. Amylase and urease activities were detected in majority of the strains but lipase and protease activities were not detected. Long chain, saturated, unsaturated and branched fatty acids were predominant in the psychrotolerant bacteria.


Subject(s)
Bacteria/growth & development , Bacteria/genetics , Bacteria/isolation & purification , Ice Cover/microbiology , RNA, Ribosomal, 16S/genetics , Soil Microbiology , India , Soil
11.
Extremophiles ; 14(4): 377-95, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20505964

ABSTRACT

The bacterial diversity of two soil samples collected from the periphery of the Roopkund glacial lake and one soil sample from the surface of the Roopkund Glacier in the Himalayan ranges was determined by constructing three 16S rRNA gene clone libraries. The three clone libraries yielded a total of 798 clones belonging to 25 classes. Actinobacteria was the most predominant class (>10% of the clones) in the three libraries. In the library from the glacial soil, class Betaproteobacteria (24.2%) was the most predominant. The rarefaction analysis indicated coverage of 43.4 and 41.2% in the samples collected from the periphery of the lake thus indicating a limited bacterial diversity covered; at the same time, the coverage of 98.4% in the glacier sample indicated most of the diversity was covered. Further, the bacterial diversity in the Roopkund glacier soil was low, but was comparable with the bacterial diversity of a few other glaciers. The results of principal component analysis based on the 16S rRNA gene clone library data, percentages of OTUs and biogeochemical data revealed that the lake soil samples were different from the glacier soil sample and the biogeochemical properties affected the diversity of microbial communities in the soil samples.


Subject(s)
Bacteria/classification , Biodiversity , Bacteria/genetics , Bacteria/isolation & purification , Base Sequence , Cloning, Molecular , Colony Count, Microbial , DNA Primers , India , Polymerase Chain Reaction , RNA, Ribosomal, 16S/genetics
12.
J Clin Pathol ; 63(2): 147-50, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20154037

ABSTRACT

BACKGROUND: Haemoglobin E (HbE)-beta-thalassaemia has a very variable clinical presentation. The management of severe cases that are often transfusion dependent is similar to that of cases of beta-thalassaemia major; however, this is often not possible in India because of its high cost and the lack of availability of safe blood at many places. Thus there was a need for a drug such as hydroxyurea, which is known to reduce the transfusion requirements of patients with thalassaemia intermedia. This study was undertaken to evaluate the response of Indian patients with HbE-beta-thalassaemia to hydroxyurea. MATERIALS AND METHODS: 11 patients with HbE-beta-thalassaemia receiving regular transfusion plus two less frequently transfused patients were selected for hydroxyurea therapy. Clinical and haematological evaluation was performed before and after treatment for 2 years. Molecular studies included beta-globin genotype, beta-globin gene haplotype, Xmn I polymorphism and alpha-genotyping. RESULTS: Four clinically severe patients became transfusion independent (responders) after hydroxyurea therapy, four patients showed a reduction in their transfusion requirements (partial responders), and three patients were non-responders. Responders showed a statistically significant increase in Hb, mean corpuscular volume, mean cell Hb, fetal Hb and F cells with a reduction in their transfusion requirements. A reduction in serum ferritin concentration was also seen in responders and non-responders. CONCLUSIONS: Genetic markers such as Xmn I polymorphism and alpha-gene deletions were not always beneficial for the response to hydroxyurea therapy. Thus many more markers and a larger cohort need to be studied to predict the response in these patients.


Subject(s)
Blood Transfusion , Hemoglobin E/analysis , Hydroxyurea/therapeutic use , beta-Thalassemia/drug therapy , Adolescent , Adult , Child , Combined Modality Therapy , Deoxyribonucleases, Type II Site-Specific/genetics , Ferritins/blood , Genotype , Humans , Mutation , Polymorphism, Genetic , Treatment Outcome , Young Adult , beta-Globins/genetics , beta-Thalassemia/genetics , beta-Thalassemia/therapy
13.
Curr Microbiol ; 59(5): 537-47, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19680721

ABSTRACT

Culturable bacterial diversity of seven marine sediment samples of Kongsfjorden and a sediment and a soil sample from Ny-Alesund, Svalbard, Arctic was studied. The bacterial abundance in the marine sediments of Kongsfjorden varied marginally (0.5 x 10(3)-1.3 x 10(4) cfu/g sediment) and the bacterial number in the two samples collected from the shore of Ny-Alesund also was very similar (0.6 x 10(4) and 3.4 x 10(4), respectively). From the nine samples a total of 103 bacterial isolates were obtained and these isolates could be grouped in to 47 phylotypes based on the 16S rRNA gene sequence belonging to 4 phyla namely Actinobacteria, Bacilli, Bacteroidetes and Proteobacteria. Representatives of the 47 phylotypes varied in their growth temperature range (4-37 degrees C), in their tolerance to NaCl (0.3-2 M NaCl) and growth pH range (2-11). Representatives of 26 phylotypes exhibited amylase and lipase activity either at 5 or 20 degrees C or at both the temperatures. A few of the representatives exhibited amylase and/or lipase activity only at 5 degrees C. None of the phylotypes exhibited protease activity. Most of the phylotypes (38) were pigmented. Fatty acid profile studies indicated that short chain fatty acids, unsaturated fatty acids, branched fatty acids, the cyclic and the cis fatty acids are predominant in the psychrophilic bacteria.


Subject(s)
Bacteria/enzymology , Bacteria/isolation & purification , Bacterial Proteins/chemistry , Biodiversity , Geologic Sediments/microbiology , Amylases/chemistry , Amylases/metabolism , Arctic Regions , Bacteria/chemistry , Bacteria/classification , Bacterial Proteins/metabolism , Culture Techniques , DNA, Bacterial/genetics , DNA, Ribosomal/genetics , Lipase/chemistry , Lipase/metabolism , Molecular Sequence Data , Peptide Hydrolases/chemistry , Peptide Hydrolases/metabolism , Phylogeny , RNA, Ribosomal, 16S/genetics , Svalbard
14.
Clin Chim Acta ; 407(1-2): 10-5, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19545554

ABSTRACT

BACKGROUND: The clinical and hematological response to hydroxyurea was evaluated in beta thalassemia patients in western India with variable clinical severity and correlated with genetic factors. MATERIALS AND METHODS: Seventy-nine patients-[38-beta thalassemia intermedia-(group I), 41-beta thalassemia major-(group II)] on hydroxyurea therapy were followed-up for 20-24months. RESULTS: Among the frequently transfused patients in group I, 58% became transfusion independent and 16% showed a 50% reduction in transfusions after therapy which correlated with a higher mean fold increase in HbF and gamma mRNA expression levels. Forty-one percent of patients in group I had associated alpha-thalassemia and 72.7% were XmnI (+/+). beta thalassemia chromosomes among the responders of group I (41%) were linked to haplotype (- + + - + + - - +) as against haplotype (+ - - - - - - - +) being more common among the non-responders. Response was not linked to the beta thalassemia mutations. Thirty-two percent of group II patients showed a 50% reduction in their transfusion requirements after therapy which also correlated with a higher mean fold increase in HbF and gamma mRNA expression levels. A significant decrease in serum ferritin was seen in both groups. 19% of patients could not tolerate the drug. CONCLUSIONS: In group I, clinical response to hydroxyurea was better in patients with alpha-thalassemia, XmnI (+/+) and a higher mean fold increase in gamma mRNA expression. In group II, only one-third of patients showed a partial response.


Subject(s)
Hydroxyurea/therapeutic use , beta-Thalassemia/drug therapy , beta-Thalassemia/pathology , Adolescent , Adult , Child , Child, Preschool , Female , Fetal Hemoglobin/metabolism , Gene Expression Regulation/drug effects , Haplotypes , Hematology , Humans , Hydroxyurea/pharmacology , India , Male , Mutation , Polymorphism, Genetic , RNA, Messenger/genetics , RNA, Messenger/metabolism , Repetitive Sequences, Nucleic Acid , Treatment Outcome , Young Adult , beta-Thalassemia/blood , beta-Thalassemia/genetics
15.
Am J Clin Pathol ; 130(2): 202-9, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18628088

ABSTRACT

Our purpose was to develop and evaluate isolation and enrichment of fetal erythroblasts and a nested polymerase chain reaction (PCR) approach using fetal erythroblasts for detecting the beta-globin gene mutations for a noninvasive prenatal diagnosis of hemoglobinopathies. Maternal blood at different periods of gestation was layered on a Percoll density gradient for enrichment of fetal nucleated RBCs (NRBCs). A combination of 3 monoclonal antibodies (CD45-peridinin chlorophyll protein, glycophorin A-phycoerythrin, and anti-hemoglobin F-fluorescein isothiocyanate) was used for flow cytometric sorting of fetal NRBCs from enriched cells. Different nested PCR-based approaches were used for identification of fetal mutations. Owing to heterogeneity of beta-thalassemia mutations in the population of India, we had to screen for 12 mutations and were able to give an accurate diagnosis in 84 (84.0%) of 100 cases when compared with chorionic villus sampling or cordocentesis and DNA analysis.This nested PCR approach enabled amplification of small quantities of DNA from fetal erythroblasts, providing a cost-effective method for noninvasive diagnosis.


Subject(s)
Antibodies, Monoclonal , Globins/genetics , Hemoglobinopathies/diagnosis , Polymerase Chain Reaction , Prenatal Diagnosis/methods , Cost-Benefit Analysis , Erythroblasts , Female , Fetal Blood , Genetic Testing , Humans , India , Minisatellite Repeats , Mutation , Pregnancy , Prenatal Diagnosis/economics
16.
Stem Cells Dev ; 15(3): 305-13, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16846369

ABSTRACT

CD34 is highly glycosylated surface antigen of enormous clinical utility in the identification, enumeration, and purification of engraftable lymphohematopoietic progenitors for transplantation. However, recently its importance in the specific marking of most immature hematopoietic stem/progenitor cells have been questioned by addressing long-term reconstitution capability of CD34(-) hematopoietic cellular fractions. These controversies have stimulated a demand for elucidation of the structure, function, and molecular interactions of CD34 to define exactly its biological significance in clinical regimens. There is accumulating data showing the participation of CD34 in adhesion or perhaps homing of lymphohematopoietic progenitors. On the other hand, CD34 has been demonstrated to down-regulate cytokine-induced differentiation and proliferation of CD34(+) cells. Studies in CD34 knockout mice revealed normal hematopoiesis but a profound delay in hematopoietic reconstitution after sublethal irradiation of the mice. In short, CD34 expression is likely to represent a specific state of hematopoietic development that may have altered adhering properties with expanding and differentiating capabilities in both in vitro and in vivo conditions. This article focuses on the adhesive properties of CD34 and its potential role in homing, which are likely to mimic lymphocyte homing to the inflammatory sites.


Subject(s)
Antigens, CD34/metabolism , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/physiology , Animals , Cell Adhesion/physiology , Humans , Models, Molecular
17.
J Biotechnol ; 126(3): 374-82, 2006 Nov 10.
Article in English | MEDLINE | ID: mdl-16787678

ABSTRACT

The genus Pseudomonas is a group of gram-negative, motile, rod-shaped bacteria known for their metabolic versatility. One of the species is Pseudomonas fluorescens, which has an efficient system for detoxification of industrial waste. Other aspects include, catabolic versatility, excellent root colonizing abilities and capacity to produce a wide range of antifungal metabolites. They are also known for their resistance and survival in the presence of several organic and inorganic pollutants. P. fluorescens has also been isolated from metal polluted water and soils but the elucidation of proteins responsible for its survival is still not clear. The aim of the study was to elucidate the differential protein expression of this bacterium when exposed to heavy metal stress, using two-dimensional electrophoresis. The proteins spo VG and enolase showed upregulation during the bacterial exposure to lead and copper. Hypothetical protein showed downregulation when bacterium was exposed to cobalt. Some proteins like xylosyltransferase, ORF 18 phage phi KZ, OMP H1 and translational elongation factor EF-Tu appeared only during their exposure to cobalt. These were absent in the control condition. Analysis of the differentially expressed proteins as well as the newly synthesized proteins along with the results obtained growth and enzyme activity indicate the involvement of all these factors in the survival of this organism in the presence of heavy metals.


Subject(s)
Bacterial Proteins/metabolism , Metals, Heavy/administration & dosage , Oxidative Stress/drug effects , Oxidative Stress/physiology , Proteome/metabolism , Pseudomonas fluorescens/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Resistance, Bacterial/drug effects , Drug Resistance, Bacterial/physiology , Pseudomonas fluorescens/drug effects
18.
Stem Cells Dev ; 14(5): 470-7, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16305332

ABSTRACT

The monomeric 115-kDa surface protein CD34, which is present on many stem cell populations, has been useful to enumerate the quality and viability of cell suspensions for engraftment. Although these studies assure the validity of CD34 as a stem cell marker, the functional role of this molecule has not been defined. CD34 has been demonstrated to regulate adhesion, differentiation, and proliferation of hematopoietic stem cells and other progenitors. The cytoplasmic domain of CD34 is known to be essential for its function. However, it is not clear how this domain's interactions with other molecules support the functional activity of CD34. Here we show that the cytoplasmic tail of CD34 is structurally similar to the carboxyl terminus of the gap junction protein Connexin 43 (Cx43). Because the activity of CD34 is mediated through its interaction with an SH3 domain of an intracellular protein, we attempted to define the SH3 binding region and amino acids involved in this interaction. We identified Glu325 to Ser334 as potential SH3 binding sites. Our results suggest that the interaction of the cytoplasmic tail of CD34 with the shallow proline-rich motif-binding groove of Crk-L is essential for the function of CD34 in stem cell development.


Subject(s)
Adaptor Proteins, Signal Transducing/chemistry , Antigens, CD34/chemistry , Nuclear Proteins/chemistry , Protein Structure, Tertiary , src Homology Domains , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/metabolism , Amino Acid Sequence , Antigens, CD34/genetics , Antigens, CD34/metabolism , Humans , Models, Molecular , Molecular Sequence Data , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Protein Binding , Protein Folding , Reproducibility of Results , Sequence Alignment , Stem Cells/physiology
19.
Exp Cell Res ; 152(1): 188-94, 1984 May.
Article in English | MEDLINE | ID: mdl-6201371

ABSTRACT

In sea urchin, unfertilized eggs have a very high level of dCMP-aminohydrolase (dCMPase) activity, which decreases gradually and at the pluteus stage it is only about a quarter of that found in the unfertilized egg. But in abnormal embryos and in disaggregated cells from embryos, no decrease in the dCMPase activity takes place. To understand the control mechanism involved in this enzyme activity during development, we have analyzed the effect of various drugs which interfere with information transfer, such as actinomycin C, puromycin, 5-azacytidine, 2-thio-uracil and p-fluoro-DL-phenylalanine on dCMPase activity in embryos of Paracentrotus lividus and Sphaerechinus granularis. Among these drugs only actinomycin induces a remarkable increase of the dCMPase activity in embryos with respect to unfertilized eggs. Puromycin has a differential and dose-dependent effect. Other drugs, although they affect normal development and macromolecular synthesis, do not significantly alter the dCMPase activity. On the basis of these results we suggest the presence of a repressor mechanism in the control of dCMP-aminohydrolase level during early embryogenesis of sea urchin.


Subject(s)
DCMP Deaminase/metabolism , Embryo, Nonmammalian/enzymology , Nucleotide Deaminases/metabolism , Animals , Azacitidine/pharmacology , DNA/biosynthesis , Dactinomycin/analogs & derivatives , Dactinomycin/pharmacology , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/metabolism , Female , Ovum/enzymology , Protein Biosynthesis , Puromycin/pharmacology , RNA/biosynthesis , Sea Urchins , Thiouracil/pharmacology , p-Fluorophenylalanine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...